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have shown that CFT cannot differentiate between species of
Trypanosoma as the CFT is not species speciﬁc [5]. The diagnostic
signiﬁcance of this test is therefore doubtful in countries where
both T. equiperdum and T. evansi infections occur. Human
sleeping sickness [6] caused by T. gambiense and surra in camels
caused by T. evansi [2] can be diagnosed with T. equiperdum
antigen. In collaboration with the Instituto G. Caporale, Teramo,
Italy, we received 8 conﬁrmed Dourine positive equine sera
samples of different titres collected during the Italian outbreak
in 2011 [4]. These 8 sera were further tested at CVRL using an-
tigen preparations from 7 different T. equiperdum strains
including ITMAS 170108 (OVI), ITMAS 070109 (Botat), ITMAS
261003B 943 (Ethiopian), ITMAS 220101 (American), ITMAS
211199A (French), ITMAS 241199B (German), ITMAS 290101
(Canadian), as well as T. evansi strain. T. evansi strainwas isolated
from a dromedary in Dubai [3]. The results of these in-
vestigations are summarized in Table 1. As seen from the Table, 8
sera reacted with different titres against different T. equiperdum
strains as well as T. evansi. This proves that standardization of T.
equiperdum antigen for use in CFT is an important issue.Table 1
CFT results of 8 Dourine-positive Italian horse sera using T. evansi and different strains of T. equiperdum antigens
SAMPLE ID CVRL CFT CFT CVRL CFT ** (with different T. equiperdum strains)
T. evansi* Teramo, Italy Ethiopian Ag Ovi Ag French Ag Canadian Ag German Ag BoTat Ag American Ag
NAM 3 1:20++++ 1:320++ 1:160+ 1:80++ 1:40++ 1:40+++ 1:80++++ 1:80+ 1:80+
NAM 4 1:40++ 1:640++ 1:160++ 1:80++ 1:40++ 1:80+ 1:160+ 1:80+ 1:80+++
BATCH 0036 1:20+++ 1:2560 1:40+ 1:40+++ 1:40+ 1:40+ 1:80+ 1:20++ 1:80++
BATCH 0037 1:20+ 1:160 1:40++ 1:40+++ 1:20+ 1:40+ 1:80+ 1:40+ 1:40++
BATCH 0039 Negative 1:10 1:2++ 1:5++ 1:2+ 1:2+ 1:5++ 1:2++ 1:5++
BATCH 0038 1:160+ 1:2560 1:640++ 1:320++ 1:320+ 1:320+ 1:320+ 1:320+ 1:640++
BATCH 0040 1:10++++ 1:160 1:40+ 1:40+ 1:20+ 1:10+++ 1:80+ 1:20++ 1:40++
BATCH 0041 1:5++++ 1:160 1:10+ 1:5+++ 1:2+++ 1:5+++ 1:10++ 1:10+ 1:5+++*The optimum dilution of T. evansi antigen for CFT testing has
been obtained by performing checker board with T. evansi posi-
tive serum
**The optimum dilution of different isolates of T. equiperdum
antigen for CFT testing has been obtained by performing checker
board with T. equiperdum positive serum.
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A molecular survey of equine piroplasms was conducted using
samples collected from symptomatic and asymptomatic horses of
Central Italy. Case deﬁnition for the acute form of piroplasmosis
was temperature >38C and at least one of the following signs,
jaundice, anaemia and petechial haemorrhages, and a PCR posi-
tive result. Phylogenetic analysis was conducted on sequences of
78 blood samples collected in 2013/14, having either low Ct values
in real-time PCRs (46 samples) for the parasites or a PCR pos/
ELISA neg (VMRD, USA) result (32 samples). Sequencing was
performed on the V4 hypervariable region of the 18S rRNA genewhich was 390 bp for B. caballi and 430 for T. equi [1, 2]. Using
BLAST, sequences were aligned with those deposited in GenBank
for both piroplasms, having a minimum 98% query coverage and
>97% homology. Genetic distance and homology conﬁrmed that
sequences of both parasites could be divided into the 3 groups,
with a homology among the groups >97% [1, 2]. Group 1 included
sequences homologous to ﬁrst-ever reported piroplasms, group 2
to the “like genotypes” [1], and group 3 included those with
equidistant homology for the two groups [2]. Among the 72 se-
quences identiﬁed as T. equi, 39 belonged to group 1, 24 to group
2, and 9 to group 3. Group 1 included 62% (24/39) of the se-
quences of symptomatic horses, while 96% (23/24) of T. equi like
(group 2), were from asymptomatic horses. Studies report that
sequences within group 1 and 2 are in all endemic areas, while in
America only group 1 and 3 are present. To date, sequences
belonging to Group 3 were never submitted for Europe and Asia.
Of the 27 T. equi PCRpos/ELISAneg samples, 23 (85.1%) had Group
1 sequences with 19 of them from symptomatic horses. For B.
caballi, 7 sequences were obtained, of which only 2 were from
horses positive for ELISA, 4 belong to group 1, 1 to group 2, and 2
to group 3. No clinical signiﬁcance was attributed to this parasite
due to the limited number of sequences available. Sequences
within the same groups and their wide geographic distribution
suggest that the diversity could be independent from their origin
and probably linked with the international movement of equidae.
The present study is the ﬁrst to report group 3 for both parasites
10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S45eS55 S55in Europe. Further studies are required to investigate the rela-
tively low sensitivity of the ELISA and the possible correlation of
the clinical evolution of the infection with the genetic group.
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The control of nematodes in grazing equids has been reliant on
the intensive use of anthelmintic drugs for many decades. This
has resulted in the development of resistance against the
commonly used anthelmintic drugs in many countries. We un-
dertook a survey to investigate the prevalence of anthelmintic
resistance on 14 Thoroughbred- and two donkey- populations in
Ireland. Anthelmintic efﬁcacy against nematodes was determined
by calculating the percentage reduction in the faecal egg count
(FEC) between the group mean at Day 0 and Day 14 post-treatment. FECs were performed using the mini-FLOTAC tech-
nique. Animals were treated with either benzimidazoles, iver-
mectin or moxidectin drugs. Thresholds for appropriate efﬁcacy
were chosen at an arithmetic mean FECR of >95% for ivermectin/
moxidectin and >90% for benzimidazole drugs. Based on these
criteria, resistance to benzimidazoles was found in 1 group of
adult mares (FECR¼38%) and in in three groups of yearling horses
(FECR range 0-86%). Ivermectin was effective on all populations
with a FECR range between 95-100%. Reduced efﬁcacy of mox-
idectin was observed in one yearling group (FECR ¼ 67%) and in
two adult mare groups (FECR range 89-92%). In addition FECs
were also calculated at 2 week intervals for up to 16 weeks after
anthelmintic drug administration to determine the egg reap-
pearance period (ERP) for benzimidazoles, ivermectin and mox-
idectin. ERP was deﬁned when the group arithmetic mean FEC
exceeded 10% of the group arithmetic mean FEC at Day 0. The
results indicated that ERP for moxidectin and ivermectin ranged
from 28 e 56 days and 14 days for benzimidazoles. Overall the
results from this study indicate that benzimidazole, ivermectin
and moxidectin are still effective on the majority of farms. How-
ever, ERP results would suggest that these products are less
effective compared to label claims as a shortened ERP is believed
to be an early indicator of resistance. This highlights the need for
more targeted approaches in the control of nematodes in Irish
equine populations to slow down the impending development of
multi-drug resistance parasite populations.
